Bộ Môn Gây Mê Hồi Sức
BÀI BÁO CÁO
THUỐC TÁC DỤNG LÊN HỆ HÔ HẤP LIÊN
QUAN ĐẾN GÂY MÊ HỒI SỨC
Nhóm 4 - Lớp CNGMHS13
GVHD: Nguyễn Hưng Hòa
!"#$%&
%
MỤC LỤC
#
A. GIỚI THIỆU
' (')*+, /" 0/102 3425 46.70'!
!8 9:0, /-; 12)6<=./)*+,
1.5:)*+,+101> )?=
0/@
A B ' C+,D3: 8E FGH(100; I
D"!JK50J0C6 -=
A L < M 0/)NH!-+9 O++P@
•
• /0 Q0
C+,1/:L;!)N!-1 @
C+,1/ F -0L;!
C+,1/H<+RE
C+,1/00C!S
CH21/: ; 8.
B:!C! . 3TFU
B. NỘI DUNG
I. THUỐC TÁC DỤNG LÊN TRUNG TÂM HÔ HẤP
C .'!!8E )9 LEV1./-+RH3).L
;!"K.F6.3+W!+.XOY+!O=
I.1. Thuốc kích thích thông khí
' C+,E )9 LEE0H< LE4Z ?=./[ C
-.>' (10).L;!4\G3EC=]+,@
• T F.O10J F\H<+RE F -0=
• ^O Y10+O10J0)9 ! F
_
\+Z46 F -0L;!=
• EO 0+O5K!F0E F9 3!1/ F -0L;!=
C; E L;!)NELH+PE0:L;!4Z`530
EH)*+, FH6W5M1a.L;!64:-HbH
0D H=
c
F[ F<!4:-4ZD3L;! M LE- 1)919
; =H'C E L;!)NH)*+, F02 H?
V1EC!G :+PH( LE- EL')d=
DOXAPRAM
A C+P@
K!F0HeHZ FC F<!)@
• fgVDKh!!S!R5+. FM)9K.'\ F C ; =
• fgVC43DKJ.F F1i9)!R =
• 'HV 2EjJ=
• [ FZE Fk)4Z \=
• lJ0 LE 9!C =
• CG;! F80 F64:!S ?N0b mWn=
A F 0/@
• K!F0E L;! F F<! 0/10).L;!=
• T*+,jC1 J0H"HV4: F).L;!+W!+ F"'
102 )919 :G)5oC C-HECEC5MEL
0; C+,J0H=
A B1"H<+P@
• H /0 Q0"8 /005o1$"&0=)N' C+,
Ep+&A%$!a =
• +PH(;!D" F. Q01/ ,5o1%A#=
A C+,!,@
• E3 !5oC )DECfE 0+O"K!F0)NE
1/02 ) F -0EC0V+P F -0L;!5R16.3=
• C C+,!,@0; 6"HS0L"1-"4"+qEH2".
801R"HH8"JC"0" g.3 C!"F1=
• K!F0H.('4\/8 FC)*+,EDg4Z
`=
I.2. Tác nhân đối kháng Opioid
B a!gV)9).L;!KJ.F+W!+=./"!J1IE)*
+,H(ELJ\H3 C+,J0H6W!+=
NALOXONE
A C+P@
f1KOHeHZ+P FC F<!)@
• T.L;!\ Fk)G)+<0h)*+,W!+ FjC FM.(+
5Hk=
• B02 rHCE./-65:10+ZGH5).L;!1
ELFsF=
A F 0/@
• 'J M FD3L;!) 0/++PW!+=
• ).L;!) 0/=
A B+P"H<+P@
• ' (H /04?!V /0 Q0"1+P\< F\ @
$"t0
• B F4M@%0uE /0 Q0
t
• f3+. FMJ0H@$"$t0 /0 00vc!a H3EZ! \ F/
%#18u!a
• B+. FM@#0u!a F. Q0H( FC).L;! F\1
• O+s<4:V NH3E3 C+,6W!+
A C+,!,@
• BZ! 0" g.3 C!"!P!S
• C+,EL00; 6f1KO1HJ1 C+,J0
H6W!+=
I.3. Tác nhân đối kháng Benzodiazepine
B02 1 HEC5oXOY+YO!O"' FH('JC , (
6XOY+YO!O"10HJ0J\6XOY+YO!O"40J
85J0 LE=
FLUMAZENIL
A C+P@
w10YO1HeHZ FC F<!)@
• fgVCD 85).L;! F4\XOY+YO!OYO!0
5+Y10=
• BL,H(rHCE4:-'G).L;!561M4M0ELFs
=
A F 0/@
• ;0+D M F60/+XOY+YO!O F=
• ;0+D M F 8"60/+XOY+YO!OE8<4: e
+.)o0=
A B+P"H<+P@
• /0 Q00$"#0 F%&)"1 3! O$"%00vx$)3H6=
• L/+PjC%0=f3EL:jJ"/ M0./- FL
0/=
• 8 O+s<4:V N F <+Pw10YO1=
A C+,!,@
• w10YO1EL C+, F9 3!1/: 8E FG"102
GH .J\1GE.3C=
• w10YO18 .('\"5./116
HJ0E')9:+:64:=
• y[4:-4ZH2EELHE.3E)*+,5M'' (
aHr.G 47C'HJ[ CH2 F
G6XOY+YO!O=
&
II. THUỐC TÁC DỤNG LÊN KÍCH THƯỚC CỦA ĐƯỜNG HÔ HẤP
fZ!H/
z
4M <6G FGH<L;!1E3 jJ6)9-47[C
CH2H1!J\6J0m6.31{
#
n5!'J0=
y;!H2 34"{
#
A^+FOOF1 1/E3 5oC , (0 34H(E
^+O.1 O.1)O=; .Ka C)9.(HS6^+O)OF!)! Om^n
5i!)! O^+O)Om^n F 34=LjC: OY.0O
ECm)On"^10 b G FG!3jJ=^5i 4Z 4; 4\0O
)!+O) OF)OH()JK; &|^=f1"C1 10J00DH2^'
( F ? !3jJ=
1OF CH21/C , (0)FH(E l.1 O.1)O"
.(HSl)OF!)! Omln 5i!)! Ol)Omln=
lK./) )O" ? !3jJ=H' 1OF10 gl5
? !3jJ" FE EC1OF10J0)J1l5
b!3jJ=fZ!H/
z
G FG!3jJ 4; E} <; HZHHKC
HZ4\)9-47[H26^5l=
) 05C0O+ FEC>H'02 5 Fij F F5: aHr.
? !3jJm , (n"HV4: 1 FC M FjC0R"!JD "+ZD"
O).q5q0 FPL;!=C; SHZ0)+0F01. O5C
; EC5/0) OF+)' (10J0VgV ? !3jJ F[
F<! F/=
Các tác nhân ảnh hưởng đến đường hô hấp
x
lb!3jJ
:J010 g^24
; 65{
#
O .1K O)
^ 1OF)
? !3jJ
; E :!'J010 gl
24
1OF
~
#
HEC
F 5/0
ZD5jC0R
? !3jJ
; SHZ0)+0F01. O
T OF+)
II.1. Thuốc giãn phế quản
? !3jJ+RH3[/
z
jJ)@
• gE' \
• 3 LE
• ]u•EL-47=
• 3K.0C
• T.J0EJg
, /6H FZ b!3jJ1H(HJ[ CH2.=P.
25 M F64:-" b!3jJ' (H+P F)9L1!
V1Hv F4\C4:!C!ECH FZ5oK."HL
z
r06C1EJ0
D €"EC)"5 1I FZ1:5 \0C.=X1 b!3jJH)*+, F
1-0)@
• 65-
z
{
#
A^+FOOF
• O .1K O)
• EC1OF=
T+0F01. O' (SHZ0g€ ? !3jJ"EL
b!3jJ=H'"C1 .EL:jJE ? !3jJHbKJ.F=
•
II.1.1. Thuốc chủ vận β
2
-Adrenergic
‚!O!FOHbH)*+, FH FZ4:O).q €H8 3Eƒ#$=f10
gH2246^" 65-
z
{i' C+,4S)EC F/H<
L;!"HCaI; 1D3H 34) JFC; F=
Ảnh hưởng của chất chủ vận β
2
lên đường hô hấp
V:
LHV:'
4S)
g^245 ? !3
jJ
* fgV 340) 3 F;
F=
„fgV 3 +Z5FiFe
00C=
„fg€!P!S=
„g 3 ; 8.=
„gJ!'1F.=
„i€ S G0L F
4\WK. 9+=
„lJ0 F^O .11O F+
8E1OF4\ , ({
#
=
f[ CH2.1 F Lj , ({
#
"H1F2FE?!H<L
;!1o5`=
A C+P@
• O).q=
• W=
• gL;!\4:- \0C.=
• ? !3jJ F4\C!JD+ZD5)!J5:=
• ? !3jJ)E !J; H2=
A B9 @
• ‚!O!FO"‚!O+FO5…)!F OFO1 FoH HH)*+,b
!3jJ=]/
z
)*+,aHbH3+' C+,!,1/ 00
KJ.F+C , ({
%
†4 <; 65-
z
{
#
H /G=./"
‚!O!FO5R1 H F)!J5:E')9E3 !6{%"
{#5; 65‡=
• 2 ) 4: - 4Z 4: O ).q ;! HC! D ; 1 +P
‚!O!FO+o+" F!81oC4:-"65{
#
1
MT14 01VOF4 1O1 19H8 /4\5Ma 'EJ
g FC C+,{
%
EL00=./"81IF7
16 65{
#
e1 GH5\1V')9:+:
ˆ
6.3 J\m 3WK.0C".!OF!n; 65{
#
>' (
F/
z
D{
%
=
A C+,!,6 65{@
• l 1-"4
• l L"'
•
• .3 C! g
• H8
• '0V
1!G!C!H194\5MC C+,!,6 )NHJ0
(=L
z
)1 ' ('/
z
jJG5M' CHL
z
H3C 3440V m 3
4) 5 344(0Ln04M <EL ( 3!H3+PH< /0=
T14 01' (H)*+,47+4M!C!); m%$$‰0v18!5o1
+P1%A#18!n=/
z
jJEp+ €tAx=>' (H.( 0L
z
+E+)NH.(WK.47C)*+,0V "V5oC1E \
\4:- \0C.=P0,H." H)*+,02 1#"&A&00vtAx
<='EJg FC C+,!,EC1 .H)*+,\+
E+DEL!J102 4M!C!); 5M4M!;!02 1`G5
e1/
z
;! `G=
ŠEL'1GE 5' ( FC C+,!,G=/0 Q0
H)*+,102 !G!C!PE ? !3jJ1F; /0 F0
!EL'EJg;! C 340, /=/0 Q0' C
+,!,5/!J O+s4:-V N=
A C+,!,@
f[1: E/ F/4JC C+,!, 65-
z
{40[H
)H @
• ‹G+ CH2 F9 3!1/C , ({
#
FGKG
• 10C+ g;! 614\GKGmj F6C
, ({
#
n
• :D.('A gH2 F.3 G6^+4p 9+"
…)1"l1)O".F5 O5B O
• y1"C; E {%' ( FDF1Z! 0.(0"
HV4: 1 M F 3WK.0C5 g4+K .3 =
Œ
II.1.2. Methylxanthines
f[ CH2b!3jJ00N6!/H'H3 F 3Eƒ%Œ=
O .1K O)"'1/jH3!/"HbH)*+,F2FbH(E(0)C 4:O
).q €g0%Œc$=O!.11O1!; <H)*+,; =^0!.11O
<H)*+,+o+0i 'DG•&•O!.11O5H)*
+,47H< /0=O .1K O)' C+,F2Fb1/jH3C: G
jEC=CG3 C+,1/jH3b!3jJ1@
Ž3)!+O) OF)O"H.+RH3 g^24=
, (^+O)OHEC^+O)O"HV 4: 1 F C4:5 4/
z
O
).q"O!.11Og€C 34) JF) 0O=
3 F O10O2)=
Ž3F) 1+=
g 0196 65{
#
=
; JCG3.' C+,H FZ F/H<L;!5GL;!='J
\J0)DHECH<L;!"J0 HL
z
6G \5 g:6
CGL;!=C CHL
z
EC6O .1K O)'!!810 gC C+,!,
6a=
8E FG' (+RH34L"4"EH2"0; 6"
F5 =2 ) CHL
z
6/
z
8E FG' (KJ.F.J5o1
H FZ6 =
O .1K O)10 gZ! 05 g)9G 0"1 +b0:19
05' C+,H5o ; FCH S G=CF1Z! 0+qF5o1
H FZ=
O .1K O) g)94K; o ("' (1/jH3Dg6
VJ\C 3!6)9 g1 0=
O .1K O) g 3 +++." aHr.jC FM F++. 9
jJ=
A eHZ@
%$
O .1K O) 2+i#6 b!3jJ=)*+, F4:!S
? N 0b mW F W4) F 5O 10F. )O)On= l8 H "
O .1K O)iH+PH(J :EJgZH 6[4:-
Hg0)'HV4: m FkH)[n
A B+P5H<+P@
^0!.11O1 +++ZE00"+H'EL /04?!5 /0+o
+m' (!CC0Ln=P OH<5o11@##&t&$0mx%#EuE
H5o FkO0n#1802 .=5o F. Q0" F.$=&0uEum F.0G
#$!a n=f34:-Hb+PO!.11O"/+P02 *15E(0 FH2
.3 G <K./=
'01/:[0DH2b!3jJ5H2.3 G6O!.11O=
fH2 G%$0uBJ\\0DH2h"H2 F/#&0uB C+,
!,=H'"SH FZ6 h!5H2.3 G8+. FM FEJ%$A
#$0uB=Jt$• 1F O4+=O!.11OH.(C6.3\
4\FOY.0Ot&$5ttˆ"%$•H4K; jo (=
f[.3 J\H2.3 G6O .1K O)H5o1+P@
• fH2.3 G ;!
• FkO0
• a 1C
• ‚Y.0OJ0D‹U0!"‚ 1
• 3H2gF O
• 3H2g F4.+F O
H2 F.6^0!.11O/HHe!P!=<K./o
1H2.3 GH(ELJ\H3:jJH FZ5gVH2 =
A C+,!,@
• l L'
• 'ZH< /C
• F++.A 9jJ
• H8"4
• (
• BZ! 0
%%
•
• lJ01.3
C C+,!,'EJgKJ.FG\[4:-H)*+,C
b!3jJ+i , ({
#
EC"VH)*+,C J0=T9g0
)'HV4: /HC!+, FC F<! 3WK.0C" gW#0C"0;
o"J01.3 "F1Z! 0=f<4:H F. Q0O!.11O!J
H O+sV N=f3F1Z! 05J01.3 PKJ.F' ( 3 =
f3 ;.'+;:q0H2"/€5:+P 5H FZC F:D=
H2.3 G5He!P!38 3 =F02 5 F<!"
!G!C! r0 0CH+PH(14` =
II.1.3. Thuốc kháng Cholinergic
]:)*+,C.3 EC1OF5oHV b!3jJHKCHZ#
3Ee Fo"E H2+H);.EL+P10J0DO).q=^ F!O
H)*+,)H'"C C+,!,"HV4: 1 3 EL"10' F\/EL
H 2= C ! ; ^00 …!F F!0 H o :=
…!F F!0' CH2 v502 H;! , - €H<L;!5 /C=
…!F F!0':jJgV5H FZ!JK ? !3jJ=34) SHZ
>HHF02 G34S)= :jJ ; )c$Ax$!a 55
' (+. FM1/H3ˆ 3=
A eHZ@
…!F F!0 2+i#6 b!3jJ"':jJ4S)E)*+,5o
C 2+i , ({=T9 6 HbHE(0D"+H''H)*
+, FJDO).q5W=V4: ':jJ5o4:-1o S0?
W=
A B+P5H<+P@
…!F F!0H)*+,+o+4M!";!EJ#$• F%18KZ =
PcAt18u."0v18KZ %A#18=>' (H;!+o+E+"
#Ac01++ZD#&$•u01=
A C+,!,@
• L <K./KJ.F
• 3 EL"5ZH?" gbC!
II.2. Chất ổn định màng
DISODIUM CROMOGLYCATE
B02 +R); 6O11"%1 J+^!"H M0FH(4J5:
1C; +ZD=f'EL'4J; b!3jJ=
%#
A G3@
G3 H26)+0F01. O1SHZC 34) 0"
D35:)JK; C; F +ZD=B0H'E/1"gVjC
FM1=P F <+10J0 gH26 !3jJ" C
+,1/C 345/0mH 94"48+n=
lJ0HC!DjC0D6!3=F01.' C+, ? !3
jJ+E1"E \)-"V+Z./=' C+, v=
L C+, F9 3!5/0.) 0O/b!3jJEL
HCE(=e' C+, 8 a.+9!i5EL'5 Fi FH FZGO
;! =
' ( G C5oC+ 8EJ0C" C+,1/C 345/0mH
94"48+n=
A eHZ@
• 9!iO FkO0
• iG ? !3jJ+?)D.+E1
• ]/00>+ZD
• X: -0q0+4
A B+P5H<+P@
B+P@+ KZ 5M ELi 5EL;! )E=
BH8/+PH FZO\ Fk& S F\1/1#18KZ ".t18CH=
f<4:)EHbSHZ MJ0+8)+P €tKcV#18%.=
]/00>+ZD@+P FkO0x S F\1/1KZ 0v4/0>%1%$0".cAt
18CH
]/0E3 0@+P Fk €t S F\1/ €%H3# ++ZF01.t•+P
bE50v0? ".tAx18CH
P OH< 5m&$•u18KZ n=
A C+,!,@
• <V!@DH8"46"E 0:"4L"H++."5/0
++.F2 "H'.HFC \0? Cj"H *"ED"
!3jJh"5/0+•
• 30V!@ ? !3jJV" -0q048C \!S"5/0 .3
0 "E' ( :•
• JDjC0R' (KJ.F5!a )E @D"S0H." \
EiE‘".3 C!"8E'Z" g48C •
II.3. Các yếu tố kháng viêm
STEROID
A
%c
• B 5/00; 5 <H+P; F4:5/0;!5
0 =
• lH)o065/0@ T OF+ D3 C ./ ' oH2 5C
. EO aHr.5/0…BA%"…BAx" 94548 EpH3S5/0=
fF'a!J0 3 C; 50TOF ") 0O"•
• lHH5/0@T FOF+D30f FK.+O"10J0 9+fW
FH 94=
A T OF+! `)9J!'C; F'
6!JD+ZD47CD3)!1!)O=
A D36.3 F/0q+Z 34" J\ F/
0q+Z+Z (=
Thành phần Tác động và cơ chế
, ( 2 4 6
T OF+
D! , (10 .HS!/0b+R
H3 .HS; Fa!F O
B!F
g)JK; B!F D3)9)J
K; 6C; .('^+^F+"
H 94•
‚)!1) lJ0)16‚)!1)
1.0!. O)
lJ0 ) 1 1.0!. O) 5 )J K;
. EO)
94 lJ0J!'BOE FOO)5F) 1+
3420L lJ0 ;0KjC 3420L
G FG LE g’
#
A^+FOO! F)10bG
.3)) lJ0 3 8.
A eHZ@
• O).q
• X:!S!3jJ ?N0 mWn
• X: 1.0!1 mTF+))n
• X:!SEN
• X:!Sq0
T OF+ 2+iH FZ D#64:O).q;!"H :jJ; 5x
%#)E F. Q0=T OF+H+P FO).q;!EL:
jJ.1! D"FiH+P FH ;! 6W=
A B+P5H<+P@
• FO+)1O+P OH<5o1c$At$0u.")H'J0i%$A
%&0u.=FO+)1O;! )E=Œ$• 1F O
%t
4+5H.(C\=‚Y.0OJ0D4\‚ 1.‹0!
10J0 <4Cƒ6FO+)1O=
• .+FF )O+P F. Q05o1cAt0uE0vx 3=
A C+,!,@
• ‹1o5H:J
• fq0Er5M'' C+,D3: 0q+Z
• ]/01p H< /'
• fG5 OG
• .HS H2 -0 8" C!"•
T OF+)J\H383 CGj6G (=C+, - KJ.F
GE+PT OF+47H< ")N'J\ v=f38 3 +P
T OF+)"1+P8HHeH(H H)9-47[:jJ1-0)5
C+,!,=
B/jlT@ CH21/H<+REH3 0/@+P F)E!J5:"+Z
D"J0 ? !3jJ=
5o[4:-4ZO!3jJ").L;!0b" ? !3jJ ' (
E3 ! b!3jJP 0/ F!R H(HJ04JHL;!
; 4:-=
%&
III. THUỐC TÁC DỤNG LÊN MẠCH MÁU
T9HiC!1900C!S6G (<@
• S5C00C!S)JK; 5.('C; F50=
• T9!-4 8E:J0@ , (‡ 0" , ({ b0=
• ^+^F+H.(' @
A F04KO@ 0=
A F) 1+)l…
#
"l
#
@ b0=
• W
#
@ 3W
#
0" W
#
51000C\F=
• ^O .11O"^5XF+.E b0=
H FZ C+,1/00C!S110J0C!1900C!S5H
eHZ F F<!8b0)-G=e J" gC!1900C!S
14:!C!;!D 0 < F4: 04r0)=lJ0C!19. J0 J\
0!J=
C.3 CH21/C!1900C!S@
Yếu tố gây tăng áp lực mạch máu phổi
.!K
^+))
‡A^+FOOF) )
{A^+FOOF ) )
F 0O
) 0O
TOF O
^ O)……
F04KO
Yếu tố gây giảm áp lực mạch máu phổi
WK.O
^1E1))
‡A^+FOOF )
{A^+FOOF)
F) 1+l…
#
"l
#
VE/K
^‚4 F)
^O .11O
^0!.11O
%x
f F 5 F
f FK
T+0 F!F))+O
.+F1YO
YK+O
aH)*+,VrHC4H85HCCH FZ"VH(H FZ
+ F g.3 C!H20!S F F<!1-0)@
• g.3 C!H20!SHH8
• X: 04r0)
• X:51C
• X:!S ?N0b mWnV4: 0!S
• 2D).L;! 3 F(m^‹Tn
• T.L;!;!
• P!S;!
b0'++P@
A +P OH<0C5: 8
A E 5@W
#
"fW
y4:-).L;!;! V2D).L;! 3 F(" b0
+P OH<0C10 M F :G" FE +E' (J :HH'=
III.1. Chẩn đoán ban đầu và đánh giá điều trị
(HCCKC!JD600C!S1H F9 3!C!); H20
!S5110C!S= G!C! 3!ELK-01;)*+,CE
!!1OF MH6KCH(EL 3!G!C!K-01;0=(
HCC!JD600C"/+PC C- C+,!,5 <
CH2?; =
]+,@1Y1O.+F1F+OmEC , (‡5 CH2b0 F9 3!n5o
02 1$=&A%=$0=E
A%
< F/Gc$ S"5 -0Q!JVH2
0!S'1N1 <+P; H(HCC)9HC!D00C!S\4:
-'4: 04r0)"1I5o< gC!"Z! 0=C C
-EC>H)*+,H(HCC40^O .11O"F) 1+l…
#
"
f F!F))+O"^A1=
III.2. Thuốc giãn mạch
W“l‚f
WK.10b0"C!1900C
gH2WK..1! D F4: g.3 C!H20!S70
;!C!19=
F.WK.1/ , F4:!S ?N0b =
”]•f^‹‚f‚‹l…]–—fl”]•f
1Y1O"O 10O5FY)D3 , (‡A^+FOOF
…)!FO1O5OF4 1OE , ({A^+FOOF
C+,!,@H ? 9"Z! 0 g"1Z! 05F=
Š˜™fšf^f…
]OF!01"1 YO05fUO+!OgV)90+ 3WK.=
<+P F g.3 C!H20!SHH8=
%•
T›fœŠ•fž^”^^…^‹^…Wf…
F) 1+l…
#
10b0"C!1900C=
F.1/ ,F) 1+l…
#
F g.3 C!H20!S=
f'H < .3 C!G (=
EC5/0ELT OF+…+0O V^)!FD3)J
K; l…#†C C-.' (10 g)900C!S+ 3K.=
—fŸf— fl‹¡…¢
.+F1YO51Y1O1C b0!S F9 3!1Y1O
':jJV , (‡A^+FOOF G=
——fŸf—
O!.11O10b!3jJ"J\ F9 3!H3b00C
!S=
! !F1D3^ O)……"10J0)DJ00C!S=
f…‹…W“…mfWn
III.3. Nitric oxide (NO)
f FK 4.2) G C5o
'0 O0 6 O0Y0 T141O l.1 O
.1)OmTln"E )JK; l47
C.(l l=lE
F O )Olmln= l E J
!'K+9 F[ F 34G b
G=l bC00CH20
5 Q0"E 02 ).3 !/0b
10 .HS F4(:O=l' (
.(HS F\1 l<C!F O
)!+O) OF)O)=
C0 F [Gml1.OF.1F F On5
0 F mf F f Fn F Q 0 J
!'f FK 10bG"b00C
!S"1 b0':jJ=
F2D).L;! 3 F(" M F
3W
#
0CE3 ! gW
#
0C5q0
10 g)90\!SjC"
HV4: \!8 LEEp0mHe!Sn=C
.3 EC'!!810 g)90.
)9 !E3 (r" !E3 485J!'. E=0.10J0
J\ 0!J"102 G34J5:,426G (=
b0+P OH<0C CH21/ 4200C!S5
b0H <J!8 LE 5 LEEp0=]M 3" ƒ1: S110C
!S FF5P LEEp0 g1/"+RH3 g!8) 5J0W
#
0C=
f1" b0+P OH<L;!mfWn / CH2H3[
5P LE 5 b06.3 FC5P.=H' ƒ1: S11
0C!S FFC5P LEEp0J0H"10J0!8) 5J :W
#
F
0C=fWi10b!3jJ=]o[H(0."fWH+P!S43 F
[g08H =
A C)*+,@
%ˆ
fWH2t$Aˆ$!!0H)*+, F F<!1-0)@
2DL;!.;!
T.L;!J0K. \\ Fk)G)
lp!!S
g J 0!J5)..3Dg -0 ; !J)!R 0
X:5 0#1C
f0C -0 ; !J
lp! 0
fW' C+,@
lJ0)DJ00C!S"J0g -0 ; !J" g110C
H205"J08v F4'!" g:); -0 ; !J5 g
1 0=
lb!3jJ"J0!8) '!!8J :W
#
0C\4:-^‹T=
lJ08W
#
0\ Fk)G)=
L FC C+, -HCE(=]MEfWH 5"'E3
CjC!3500CF'4Z4; 4\O014=
A B1@
fWH F2 Fv!E5oH2#$A%$$!!0=
<4C6.@ €$"&A%"$ =
.( F5 F 4 3 j =
<K./ O+sH2fW5fW
#
F: !-!E5MH2
6fW'1/jH3 S)1+P5H26'=
A C+,!,@]MfW'02 O1O FH2 -+.; /+q+!JD5oK."
o")!OFK+O"1O +O"0O 11!F O"05; 4p FC;
G (@
OFK.'1!+
lJ0Dg6 . (
2 43
CE'HL
T.J0Dg6TFU
.3 H(065:+PfW@+PfW 3fW2)5!JD
? jC0D6C00C!S=H' g.G g.3 C!5).J0 FHS
E6!SHO+ 0=
Liên hệ trong gây mê hồi sức
0/D3 S!fW4\@
• lJ0 +R F. 8 E E @ J0 l1 0 O 5 : E
1OF
• g+R F. 8ED3@ gDgl^X^
FoE 0/"E(0 F4:-' g.3 C!H20!S=
F F<! g.3 C!H20!S"8HV LH20!S5
jJ1I 0/H(+. FM10C 0 ; !J5 FC.3 C!=
IV. THUỐC TÁC ĐỘNG LÊN HỆ THỐNG CHẤT NHẦY:
:jJ6: 1L.(!, 25 5h61o!8.5)9+
H261L0>=Bo!8.102 1o!EO!1)F+HV'H28.S F/1o!
.3 'H28. ;!=XM <"C; 3 € 34H5C .3 2!3
%Œ
jJ+. FM)9 3 +Z=34H 3 ; 8.5HE 4\+ 8E1
=
Liên quan đến GMHS@ + 8E1 )NJ\H3)9 3
+Z8.=C; 3 )NJ0HE+P !+=
BL0j F F5:Hr.1o!8.Fm5o4,4r"02!6V5
)5 n=ai!5oH(H+i; 8. €H<+RE4/H3
H<+RE F -0G; 8.HEF=aH '0 ? F4J%$=%#
BẢNG 10.12. CÁC YẾU TỐ ẢNH HƯỞNG ĐẾN CHỨC NĂNG LÔNG CHUYỂN
* Các yếu tố làm giảm chức năng lông chuyển
f: H2 g
L F<+
a 1C
.+F '
‹
^ F!O
l 0/
EL
W!+)
* Các yếu tố làm tăng chức năng lông chuyển
f: H2ELEEJ#tAct
.+F '
B0r0
CH2: 8EJ0
O .K O
—fŸf‹^ž^
T9.+F ' a!10)1L.(=+E' (E )9 ?
EjJ= FGH)*+,31L0>8H10)=
FGH)*+,.+F '=
B–œ
XM <H<Er05r0E F.=y F<!4:1IVEH<
+RE4Z4`jm \470:" ? EjJn" EEL"1+RH3 g
o +Z8."J0Dg1L0>")..3Dg; +:" ?N
H<+RE4\C; 3 +"5/0EjJ51p /00=
„B/jH3lT@ F.H OEjJ/H4bi47Go\
: H2G (=
£…šŠf¤
C+RK; .) OAO .1.) O' C+,? HD 8+)1U "; 8.
)N4Z? [!- *`a!5: K; +q+G=AO .1.) O'
(+: VE !J=./"5M0P6'E'Z"EDH<L;!
#$
F/5 ? !3jJ")*+,'KJ.F5;HG11=CE3 jJ *
:0 F/4:-WHb ; 5=
V. LIỆU PHÁP SURFACTANT THAY THẾ
V.1. Chất surfactant.
344(0L!3 .!O#4 3 =
!8@
• !; !)!1!+"!F O5K=
• • F; 1!10 1!)! +.11@10J0)Dg40V =
• TFU !!F O5K@a!!)!1!+ FJF2 F/40V 1o!+Z
1' !3=
V.2. Tác dụng.
A fg)9 ,+Z!P F!3=TDg40V 61o!+Z1' !3
EL[10Kh!!S0i'E.oEp+Z €005!3
=; TFU 10J0C!19."3EL)N !P!S").L;!=
A la!CE +q+ HE: )9 FHSE=
A F4:).L;!m‹Tn\ Fk 3 C@)*+,TFU . 3=
V.3. Surfactant thay thế.
y Fk'2D).L;!m‹Tn+)JK; ELH6 TFU 9/=f3
ELHH FZEZ! <")5< Fk5 5b" \0+8"G€ \Ep+" F,.
00" *5=F2D).L;! 3 F(m^‹Tn' ()JK; H6VEp0
; 16TFU 9/+2)m004ZFiFe"`20"q0
FP.3 nV)m !JE' "3 H"H8.G6++.n=T9 CH2
6 TFU - Hb 3 1!5 Fi6' F‹T\ Fk)G)" F
^‹TD0H1=
H3."[; +oH HbH/D 0g6'H( . 3
TFU )@
CTFU 9/H!-1! €o<Hk=
C3!r0 €!S1@F)FU=
C3!r0 !S4i@fO¥U =
3 !r0 TFU S! 'D02 v !6 !10 .1!)! +.1
1O"!- C5>C=
TFU 6< €<E`O0)N1)9 . 31I \"E'
Eg 9 3 F5:'HH6)15.G1 q0C4:q0 FP
m. 0O15F)"OF!O)"…]n35:)*+,'=3 K; €4iHbH)*+,
5o02 ) L F‹T6 Fk)G)"5o5:5Ri0q+Z!JD
5o01!F O=TFU S!H!F O 9+5EL'0HO+
1 q0=
Exosurf
1!F O 9+"H S!5L FP+o+42 51 F[ F-EL=
f'Dˆ$•!10 .1!)! +.11O F25oOK+O15.1K!1=T9! F2
64 !8H HC ; )1I8 3 !SH(gVKh!!3
#%
E \F=!10 .1!)! +.11O10J0)Dg40V P!;
ECa!'1 F.'5 g+: FHSE F) E}L;!=
T*+,
F‹T\ Fk'-VG•$$")*+,‚K)FUHb (:)@
• xx•J0 ƒ1: *5 €‹T=
• tt•J0 ƒ1: *5 F%g0 €4; E}./-EC=
• J :EJg))' 0EL'+Z)J!3jJ!S=
• lJ0 (C5, FE0!S5!P!SEN=
• lJ0). \0C.=
• lJ0 ƒ1:iH20=
• L')9 .HS F ƒ1:q0 FPVq0 FP.3 =
Liên quan giữa Surfactant trong hô hấp của GMHS.
S G5!P)NKJ.F3H(!S \5o1EVDgELH8.
H6V10!Sb\jC0D=
4G0TFU 5!S"TFU )NHi5o+Z!SH(10 g (
5 F19 MEL 5;H\!SDH8.+Z=]:4G0TFU 5!S0
7010J0 (4; D02 )9 .HS)1I;! FEH FZH' (
0102 )9!-4F; Ep0=+P)9!-4TFU F 9 3 MEL1I
\'>H6 +CHV 1I)6TFU 5e802 1`
€5P F!SH('HC!DH FZ=
C. KẾT LUẬN
L;!0tjC FM@ LE"E3 C" FHS"5.(=
F -0L;!4ZD34\: 8EE+P 0/" J0H"
8"===J\H3jC FM LE=
<+RE4Z1J\H3jC FM LE=
C00C1J\H3jC FME3=
T9 g 3 ; 8.J\H3jC FM LE5E3 C=
3TFU J\H3jC FME3 C=
(J :L;!"a!E1 L5 FHS "8+PC @
C+,1/ F -0L;!E LE"1C C-D3
F -0L;!=
b!3jJ"SHZ0"EC5/0"J0 3 ; 8."1H0" /
H0a!10 L CH<+RE=
bC00\!S";!; +:TFU H(0C5E
H35 FHS G=
f< 0/8j -0C5;HKJ.F FjC FML;!6<4:
5'4:!C!Jj.3 FjC FM 0/)D=
##
TÀI LIỆU THAM KHẢO
%= ]>]g>" !"#$%$&"'()*#"f“XlC+,]: f0"
#$$Œ=
#= lT=T="+"),- "f“Xf2"%ŒŒˆ=
c= 3?"F8L".,/f“XD"#$%c=
t= f.q]g€"F8•<"B-0Z>"XP]g•."f.qZ"
01$%$(#2()*#"f“X"#$$t=
5. !@uu¥¥¥=1FAO=O+=5u+.u)¥¦ FO =!1K§F1¨u!1uf0
•#$‹u‹O)!F F.= 0©EO.¨©F¨!1"%%@&$^".%Œ"#$%&=
x= !@uu0+1O=.+)=O+=5u.+)#u!1+#uTufTA
BOu0fAB^=!+U"%#@c$".%Œ"#$%&=
7. !@uu5O =0U=O+=5u+ uU1Oul•#$ F•#$+•#$1.¦•#$F•#$^
•#$uŠWfl•#$ˆ•#$W•#$^•#$…‚Š•#$W^=!+U"%%@&&".%Œ"#$%&=
ˆ= !@uu¥¥¥=U5!=Uu5O 0Ou11OF.Š!1+u&$c¦•#$fW•#$ O!=!+U" %#@c&"
.%Œ"#$%&=
#c
C 5/'0t@
%= B/Za.
#= f.qZ.3 f-
c= 0Z0f-
t= F8:f-
&= PZr0f
x= GZf8
X›flŸfªflf…«]¬
f:05, f< 9:
B0¥F+5!¥OF! !8
C+,1/ F -0L;!
a.
B0 B0 ¥F+ 5 !¥OF! !8
C+,1/H<+RE
.3 f-"0f-
B0¥F+5!¥OF! !8
C+,1/00C!S
:f-
B0¥F+5!¥OF! !8
C+,1/; 8.6!S
r0f
B0¥F+5!¥OF! !8
C+,1/; TFU
GZf8
S!¥F+ :f-
S!!¥OF! r0f
.3 FM 0f-
#t